Home » MOLECULAR DEVICES INTRODUCES FATTY ACID UPTAKE ASSAY TO TARGET METABOLIC DISEASES
MOLECULAR DEVICES INTRODUCES FATTY ACID UPTAKE ASSAY TO TARGET METABOLIC DISEASES
Molecular Devices has announced the launch of its QBT Fatty Acid Uptake Assay Kit, the first assay kit that addresses the need for a single-step, homogenous in vitro assay for fatty acid uptake for use in high- throughput screening and metabolic disease research.
News-Medical (http://www.news-medical.net/?id=7235)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct